Hm Payson & CO Pfizer Inc Transaction History

Hm Payson & CO

$5.81 Billion
Q3 2024

A detailed history of Hm Payson & CO transactions in Pfizer Inc stock. As of the latest transaction made, Hm Payson & CO holds 634,130 shares of PFE stock, worth $17.4 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

634,130

Previous 658,910 3.76%

Holding current value

$17.4 Million

Previous $18.4 Million 0.46%

% of portfolio

0.32%

Previous 0.34%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$27.7 - $31.39 $686,406 - $777,844	-24,780 Reduced 3.76%	634,130 $18.4 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $508,711 - $596,114	20,139 Added 3.15%	658,910 $18.4 Million
Q1 2024 Jun 20, 2024	SELL	$25.89 - $29.73 $2.1 Million - $2.42 Million	-81,244 Reduced 11.28%	638,771 $17.7 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $2.52 Million - $3.28 Million	-96,625 Reduced 11.83%	720,015 $20.7 Million
Q3 2023 Nov 06, 2023	SELL	$32.09 - $37.51 $2.4 Million - $2.81 Million	-74,796 Reduced 8.39%	816,640 $27.1 Million
Q2 2023 Jul 17, 2023	SELL	$36.12 - $41.79 $27.8 Million - $32.2 Million	-769,617 Reduced 46.33%	891,436 $32.7 Million
Q1 2023 Apr 18, 2023	SELL	$39.39 - $51.28 $8.71 Million - $11.3 Million	-221,097 Reduced 11.75%	1,661,053 $67.8 Million
Q4 2022 Feb 06, 2023	BUY	$41.75 - $54.5 $1.61 Million - $2.1 Million	38,584 Added 2.09%	1,882,150 $96.5 Million
Q3 2022 Oct 25, 2022	BUY	$43.76 - $53.42 $1.06 Million - $1.29 Million	24,168 Added 1.33%	1,843,566 $80.7 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $3.7 Million - $4.39 Million	79,488 Added 4.57%	1,819,398 $95.4 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $2.92 Million - $3.62 Million	63,874 Added 3.81%	1,739,910 $90.1 Million
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $1.65 Million - $2.45 Million	39,941 Added 2.44%	1,676,036 $99 Million
Q3 2021 Nov 30, 2021	BUY	$39.25 - $50.42 $268,705 - $345,175	6,846 Added 0.42%	1,636,095 $70.4 Million
Q2 2021 Aug 17, 2021	BUY	$35.91 - $40.68 $259,198 - $293,628	7,218 Added 0.44%	1,629,249 $63.8 Million
Q1 2021 Jun 15, 2021	SELL	$33.49 - $37.77 $591,533 - $667,131	-17,663 Reduced 1.08%	1,622,031 $58.8 Million
Q4 2020 Mar 10, 2021	BUY	$33.47 - $42.56 $262,404 - $333,670	7,840 Added 0.48%	1,639,694 $60.4 Million
Q3 2020 Dec 21, 2020	BUY	$31.75 - $37.25 $2.39 Million - $2.8 Million	75,287 Added 4.84%	1,631,854 $59.9 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $524,359 - $636,124	17,409 Added 1.13%	1,556,567 $50.9 Million
Q1 2020 Jul 01, 2020	SELL	$27.03 - $38.62 $2.53 Million - $3.62 Million	-93,686 Reduced 5.74%	1,539,158 $50.2 Million
Q4 2019 Feb 18, 2020	BUY	$32.92 - $37.36 $1.1 Million - $1.24 Million	33,295 Added 2.08%	1,632,844 $64 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $2.92 Million - $3.79 Million	89,926 Added 5.96%	1,599,549 $57.5 Million
Q2 2019 Aug 15, 2019	BUY	$36.98 - $41.52 $231,531 - $259,956	6,261 Added 0.42%	1,509,623 $65.4 Million
Q1 2019 Jul 31, 2019	BUY	$37.5 - $41.2 $55.7 Million - $61.2 Million	1,484,605 Added 7914.94%	1,503,362 $63.8 Million
Q4 2018 Feb 15, 2019	SELL	$38.47 - $43.86 $47.8 Million - $54.5 Million	-1,243,665 Reduced 98.51%	18,757 $819,000
Q3 2018 Nov 30, 2018	SELL	$34.47 - $41.81 $7.8 Million - $9.46 Million	-226,175 Reduced 15.19%	1,262,422 $55.6 Million
Q2 2018 Aug 27, 2018	BUY	$32.98 - $35.16 $73,347 - $78,195	2,224 Added 0.15%	1,488,597 $54 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $314,153 - $364,461	-9,845 Reduced 0.66%	1,486,373 $52.8 Million
Q4 2017 Feb 16, 2018	BUY	$33.26 - $35.29 $11,408 - $12,104	343 Added 0.02%	1,496,218 $54.2 Million
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $46.4 Million - $51.1 Million	1,495,875	1,495,875 $53.4 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account